Shao Z[au] - Search Results

Year	Number of Results
1981	1
1984	2
1985	1
1986	2
1987	1
1988	2
1990	1
1991	7
1992	18
1993	21
1994	25
1995	26
1996	23
1997	25
1998	27
1999	39
2000	24
2001	39
2002	46
2003	37
2004	53
2005	45
2006	78
2007	86
2008	101
2009	149
2010	159
2011	158
2012	192
2013	204
2014	288
2015	288
2016	291
2017	290
2018	342
2019	408
2020	484
2021	284

1

Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets.

Gong Y, Ji P, Yang YS, Xie S, Yu TJ, Xiao Y, Jin ML, Ma D, Guo LW, Pei YC, Chai WJ, Li DQ, Bai F, Bertucci F, Hu X, Jiang YZ, Shao ZM. Gong Y, et al. Among authors: shao zm. Cell Metab. 2021 Jan 5;33(1):51-64.e9. doi: 10.1016/j.cmet.2020.10.012. Epub 2020 Nov 11. Cell Metab. 2021. PMID: 33181091

2

Natural killer cells in cancer biology and therapy.

Wu SY, Fu T, Jiang YZ, Shao ZM. Wu SY, et al. Among authors: shao zm. Mol Cancer. 2020 Aug 6;19(1):120. doi: 10.1186/s12943-020-01238-x. Mol Cancer. 2020. PMID: 32762681 Free PMC article. Review.

3

Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE).

Johnston SRD, Harbeck N, Hegg R, Toi M, Martin M, Shao ZM, Zhang QY, Martinez Rodriguez JL, Campone M, Hamilton E, Sohn J, Guarneri V, Okada M, Boyle F, Neven P, Cortés J, Huober J, Wardley A, Tolaney SM, Cicin I, Smith IC, Frenzel M, Headley D, Wei R, San Antonio B, Hulstijn M, Cox J, O'Shaughnessy J, Rastogi P; monarchE Committee Members and Investigators. Johnston SRD, et al. Among authors: shao zm. J Clin Oncol. 2020 Dec 1;38(34):3987-3998. doi: 10.1200/JCO.20.02514. Epub 2020 Sep 20. J Clin Oncol. 2020. PMID: 32954927 Clinical Trial.

4

Molecular subtypes and precision treatment of triple-negative breast cancer.

Zhao S, Zuo WJ, Shao ZM, Jiang YZ. Zhao S, et al. Among authors: shao zm. Ann Transl Med. 2020 Apr;8(7):499. doi: 10.21037/atm.2020.03.194. Ann Transl Med. 2020. PMID: 32395543 Free PMC article. Review.

5

Myeloid PTEN promotes chemotherapy-induced NLRP3-inflammasome activation and antitumour immunity.

Huang Y, Wang H, Hao Y, Lin H, Dong M, Ye J, Song L, Wang Y, Li Q, Shan B, Jiang Y, Li H, Shao Z, Kroemer G, Zhang H, Bai L, Jin T, Wang C, Ma Y, Cai Y, Ding C, Liu S, Pan Y, Jiang W, Zhou R. Huang Y, et al. Among authors: shao z. Nat Cell Biol. 2020 Jun;22(6):716-727. doi: 10.1038/s41556-020-0510-3. Epub 2020 May 4. Nat Cell Biol. 2020. PMID: 32367047

6

The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination.

Parikh SR, Campbell H, Bettinger JA, Harrison LH, Marshall HS, Martinon-Torres F, Safadi MA, Shao Z, Zhu B, von Gottberg A, Borrow R, Ramsay ME, Ladhani SN. Parikh SR, et al. Among authors: shao z. J Infect. 2020 Oct;81(4):483-498. doi: 10.1016/j.jinf.2020.05.079. Epub 2020 Jun 3. J Infect. 2020. PMID: 32504737 Free article. Review.

7

Circular RNA circ-SMAD7 promoted ovarian cancer cell proliferation and metastasis by suppressing KLF6.

Zhao Y, Qin XP, Lang YP, Kou D, Shao ZW. Zhao Y, et al. Among authors: shao zw. Eur Rev Med Pharmacol Sci. 2020 Jul;24(14):7563. doi: 10.26355/eurrev_202007_22221. Eur Rev Med Pharmacol Sci. 2020. PMID: 32744668

8

Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical Trial.

Yu KD, Ye FG, He M, Fan L, Ma D, Mo M, Wu J, Liu GY, Di GH, Zeng XH, He PQ, Wu KJ, Hou YF, Wang J, Wang C, Zhuang ZG, Song CG, Lin XY, Toss A, Ricci F, Shen ZZ, Shao ZM. Yu KD, et al. Among authors: shao zm. JAMA Oncol. 2020 Sep 1;6(9):1390-1396. doi: 10.1001/jamaoncol.2020.2965. JAMA Oncol. 2020. PMID: 32789480 Free PMC article. Clinical Trial.

9

Deubiquitinase USP20 promotes breast cancer metastasis by stabilizing SNAI2.

Li W, Shen M, Jiang YZ, Zhang R, Zheng H, Wei Y, Shao ZM, Kang Y. Li W, et al. Among authors: shao zm. Genes Dev. 2020 Oct 1;34(19-20):1310-1315. doi: 10.1101/gad.339804.120. Epub 2020 Sep 17. Genes Dev. 2020. PMID: 32943575 Free PMC article.

10

Molecular Subtyping of Triple-Negative Breast Cancers by Immunohistochemistry: Molecular Basis and Clinical Relevance.

Zhao S, Ma D, Xiao Y, Li XM, Ma JL, Zhang H, Xu XL, Lv H, Jiang WH, Yang WT, Jiang YZ, Zhang QY, Shao ZM. Zhao S, et al. Among authors: shao zm. Oncologist. 2020 Oct;25(10):e1481-e1491. doi: 10.1634/theoncologist.2019-0982. Epub 2020 Jun 1. Oncologist. 2020. PMID: 32406563 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results